Stryker Injuries and Symptoms
Many people each year must undergo hip replacement surgery. These artificial hips are manufactured with multiple components made of many different materials. Due to its link to the increased risk of metallosis, the Stryker Rejuvenate Hip, which has metal on metal components, has been recalled. Metallosis is a medical condition that occurs as a result of the deposition and build-up of metal debris in the body. This can occur when medical implants with metal components are used in joint replacements. Metallosis causes soft tissue destruction, which leads to pain around the site of the implant and can often lead to rashes and other more serious health issues and conditions. These issues and conditions include discomfort and stiffness, sensitivity and/or redness around the incision area, rash, pressure or lumps near the hip, chronic fatigue, anxiety, and difficulty concentrating.
Stryker Rejuvenate Hip Studies
The Journal of Bone and Joint Surgery reported on a study of Stryker Rejuvenate hips and the patients who underwent hip arthroplasty. The hip replacements consist of a titanium-molybdenum-zirconium-iron alloy body, which is put together with a cobalt-chromium alloy neck. All of the patients involved in the study experienced soft tissue destruction and visible corrosion of the metal components of the hip occurred. These patients also had increased levels of metals in their blood due to corrosion of the metal components of the implants.
Recall and Multi-District Litigation
In July of 2012, Stryker voluntarily recalled its Rejuvenate hip product due to reports of corrosion of the metal components. A number of lawsuits have been filed as a result of the problems with the Stryker hip. These lawsuits were consolidated in May 2013. The lawsuits are now part of a Multi-District Litigation in the Superior Court of New Jersey in Bergen County.
“Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem are manufactured by Howmedica Osteonics Corporation, a New Jersey corporation d/b/a Stryker Orthopaedics, hereinafter, HOC. On July 3, 2012, HOC voluntarily recalled the hipstems “due to the potential risks associated with modular-neck stems. These risks include the potential for fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reactions manifesting with pain and/or swelling.” Possible adverse outcomes allegedly include metallosis, necrosis and osteolysis. On January 15, 2013, the New Jersey Supreme Court designated this litigation as multicounty litigation and assigned the handling of all pending and future state cases involving these components to Bergen County to be handled by the Honorable Brian R. Martinotti.”